Aeglea BioTherapeutics
- Pharmaceutical Preparations
- Waltham, Massachusetts
Compensation history
Top executives at Aeglea BioTherapeutics received an average of $1M per person in annual compensation from 2015 to 2022.
By year
- 2022
AQ$2MAnthony G. QuinnFormer President and Chief Executive OfficerJG$2MJeffrey M. GoldbergPresident and Chief Executive OfficerLS$1MLeslie SloanFormer Chief Operating OfficerJA$1MJonathan AlspaughChief Financial OfficerJK$866KJim KastenmayerGeneral Counsel, Corporate Secretary and Former Interim Chief Executive Officer
Executives
We found ten executives who work or worked at Aeglea BioTherapeutics.
Jeffrey Goldberg
Aeglea BioTherapeutics
Chief Executive Officer
Jim Kastenmayer
Aeglea BioTherapeutics
Chief Executive Officer
Anthony Quinn
Aeglea BioTherapeutics
Chief Executive Officer
Jonathan Alspaugh
Aeglea BioTherapeutics
Chief Financial Officer
Leslie Sloan
Aeglea BioTherapeutics
Chief Operating Officer
Michael Hanely
Aeglea BioTherapeutics
Chief Operating Officer
Charles York
Aeglea BioTherapeutics
Chief Financial Officer
James Wooldridge
Aeglea BioTherapeutics
Chief Medical Officer
News
Aeglea BioTherapeutics CEO Anthony Quinn's 2022 pay slips 9% to $2.4M
April 17, 2023
Aeglea BioTherapeutics CEO Anthony Quinn's 2021 pay slips 10% to $2.6M
April 21, 2022
Aeglea BioTherapeutics CEO Anthony Quinn's 2019 pay falls 35% to $2.5M
April 23, 2020
Aeglea BioTherapeutics CEO Anthony Quinn's 2018 pay jumps 274% to $3.8M
April 22, 2019
About Aeglea BioTherapeutics
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 221 Crescent Street, Building 17, Suite 102b, Waltham, Massachusetts 02453
- 6176515940
- December 31